
Dr Ben LaHood, The Power List – Top 100 Ophthalmologists Globally
South Australian ophthalmologist Dr Ben LaHood was selected to The Power List, the top 100 ophthalmologists globally. Australia’s youngest-ever nominee at just 39 years.
Leading ophthalmic trade publication – The Ophthalmologist Magazine, has today announced its 2023 Power
List included Adelaide-based Dr Ben Lahood MBCHB, PGDIPOPHTH, PHD, FRANZCO.
The Power List highlights the excellence and impact of the most influential and inspirational people in
ophthalmology globally.
At just 39 years old, Ben is the youngest Australian ophthalmologist and eye surgeon to be included in the
global top 100, the only South Australian, and just one of only two Australians in 2023 to make the cut.
Now celebrating its 10-anniversary, this list is a benchmark that recognises the genuine giants of clinical
practice and vision research. Nominated by surgeons worldwide, it highlights individuals who
have demonstrated “ten years of excellence and impact in ophthalmology.”
Dr LaHood has been recognised for his surgical services professionally as a consultant ophthalmologist at
Adelaide Eye and Laser Centre, ParkView Day Surgery and The Queen Elizabeth Hospital in Adelaide, and
Senior Lecturer at the University of Adelaide.
Ben is considered a leader in cataract and refractive surgery, which has seen him attend multiple conferences across Asia and America to educate his peers. As well as a driving force through his highly engaged digital and social media presence, newsletters, blogs, two podcasts and regular webinar events.
“I am incredibly humbled to be included in this group of the world’s top 100 ophthalmic minds. I had never assumed I would be at this stage in my career and still not be 40! Selection on this list has been a career goal and is clearly a highlight for me. I could not have gotten to where I am today, without the many opportunities I have been provided by my professional community. Thank you.
It is a personal goal of mine to challenge the current system that often restricts ‘advanced technology’ (toric and multifocal intraocular lenses) in cataract treatment for private patients only.
I believe we should be thinking about the wider benefits and long-term health benefits of these technologies
as there are wider-reaching communities that would benefit including those with dementia and other
disabilities. These technologies have been the focus of my research, PhD and publications over the past five
years.”
Jon Greenway, Editor of The Ophthalmologist, says “We are thrilled to include two Australians in this year’s
Power List. We have never had a nominee as young as Ben which is fantastic news for Australian ocular health
and for inspiring the next generation of ophthalmologists”.